Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias
- PMID: 1700749
- DOI: 10.1002/eji.1830201009
Immunoglobulin heavy chain variable region family usage is independent of tumor cell phenotype in human B lineage leukemias
Abstract
During B cell development, immunoglobulin heavy chain (IgH) variable region (VH) genes are rearranged and expressed in a programmed manner and accumulating evidence suggests recurrent utilization of developmentally restricted VH genes in malignant B lymphoid populations. We have used polymerase chain reaction gene amplification in conjunction with a panel of VH family-specific amplimers to directly compare the repertoire of VH region rearrangement in mature, CD5+ B cell chronic lymphocytic leukemia with that in immature, CD5 B lineage acute lymphoblastic leukemia. The results revealed a diverse pattern of VH family utilization common to both disease groups in which VH regions most proximal to the IgH joining locus were preferentially rearranged relative to their family sizes with recurrent utilization of several known developmentally restricted VH genes in close to germ-line configuration. These results indicate that biased VH family usage is independent of tumor cell phenotype in B lineage leukemias. This bias may reflect similar stages or compartments in normal B lymphopoiesis from which diverse types of B cell malignancy may arise. Moreover, since blast cells in acute lymphoblastic leukaemia do not express functional immunoglobulin, we infer that the tumor cell-associated VH family repertoire is determined through antigen-independent mechanisms.
Similar articles
-
Preferential rearrangement of developmentally regulated immunoglobulin VH1 genes in human B-lineage leukaemias.Leukemia. 1991 Aug;5(8):646-50. Leukemia. 1991. PMID: 1909408
-
Organization and expression of VH gene families preferentially expressed by Ly-1+ (CD5) B cells.Eur J Immunol. 1989 Nov;19(11):2115-21. doi: 10.1002/eji.1830191122. Eur J Immunol. 1989. PMID: 2480903
-
V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia.Haematologica. 2003 Nov;88(11):1259-71. Haematologica. 2003. PMID: 14607755
-
[Characterization of the immunoglobulin heavy and light chain variable region sequences from human multiple myeloma cells].Nihon Rinsho. 1995 Mar;53(3):592-7. Nihon Rinsho. 1995. PMID: 7699890 Review. Japanese.
-
Immunoglobulin V gene expression in CD5 B-cell malignancies.Ann N Y Acad Sci. 1992 May 4;651:373-83. doi: 10.1111/j.1749-6632.1992.tb24638.x. Ann N Y Acad Sci. 1992. PMID: 1376056 Review.
Cited by
-
Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical features.Br J Cancer. 1994 Mar;69(3):609-12. doi: 10.1038/bjc.1994.113. Br J Cancer. 1994. PMID: 8123498 Free PMC article.
-
Expansion of a B-lymphocyte clone producing IgM auto-antibodies encoded by a somatically mutated VHI gene in the spleen of an autoimmune patient.Rheumatol Int. 1994;13(5):187-96. doi: 10.1007/BF00390266. Rheumatol Int. 1994. PMID: 8202662
-
Restricted use of fetal VH3 immunoglobulin genes by unselected B cells in the adult. Predominance of 56p1-like VH genes in common variable immunodeficiency.J Clin Invest. 1992 May;89(5):1395-402. doi: 10.1172/JCI115728. J Clin Invest. 1992. PMID: 1569182 Free PMC article.
-
Nucleotide sequences of an antiidiotypic antibody from a transplant recipient.Immunogenetics. 1993;38(3):242. doi: 10.1007/BF00211526. Immunogenetics. 1993. PMID: 8505067 No abstract available.
-
Anti-mouse red blood cell monoclonal antibodies use functionally rearranged genes from the VH J558 family and are derived from the CD5- B-lymphocyte subpopulation.Immunology. 1993 Aug;79(4):568-73. Immunology. 1993. PMID: 7691732 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials